Home003220 • KRX
add
Daewon Pharmaceutical Co Ltd
Previous close
₩14,580.00
Day range
₩14,520.00 - ₩14,700.00
Year range
₩13,910.00 - ₩20,700.00
Market cap
327.22B KRW
Avg Volume
336.36K
P/E ratio
19.56
Dividend yield
2.06%
Market news
MarketWatch
1 day ago
Nvidia and the Magnificent Seven make up too much of your high-priced index
fund
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 156.83B | 21.59% |
Operating expense | 63.45B | 20.60% |
Net income | 6.79B | 24.40% |
Net profit margin | 4.33 | 2.36% |
Earnings per share | — | — |
EBITDA | 16.44B | 47.23% |
Effective tax rate | 32.05% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 71.78B | 116.52% |
Total assets | 598.69B | 25.11% |
Total liabilities | 308.98B | 43.76% |
Total equity | 289.71B | — |
Shares outstanding | 21.34M | — |
Price to book | 1.12 | — |
Return on assets | 4.81% | — |
Return on capital | 5.98% | — |
Cash Flow
Net change in cash
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 6.79B | 24.40% |
Cash from operations | 19.98B | 3,902.41% |
Cash from investing | -19.47B | -78.27% |
Cash from financing | -4.44B | -169.49% |
Net change in cash | -3.88B | 3.09% |
Free cash flow | -5.82B | 75.15% |
About
Founded
1958
Website
Employees
1,125
